Veradigm Inc. (NASDAQ:MDRX – Get Free Report)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $9.40, but opened at $10.00. Veradigm shares last traded at $10.00, with a volume of 3,447 shares traded.
Analysts Set New Price Targets
Separately, StockNews.com initiated coverage on Veradigm in a research note on Thursday, December 19th. They set a “hold” rating on the stock. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $11.75.
View Our Latest Analysis on Veradigm
Veradigm Stock Down 0.5 %
Institutional Investors Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC acquired a new position in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- Stock Analyst Ratings and Canadian Analyst Ratings
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- What is the Shanghai Stock Exchange Composite Index?
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- Trading Stocks: RSI and Why it’s Useful
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.